As of January 22, 2025, Nykode Therapeutics (NYKD.OL) has a market cap of $78.420 million USD. According to our data, Nykode Therapeutics is ranked No.7873 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $78.42 M |
-11.10%
|
Dec 30, 2024 | $88.21 M |
-85.77%
|
Dec 29, 2023 | $0.62 B |
-23.90%
|
Dec 30, 2022 | $0.81 B |
-65.15%
|
Dec 30, 2021 | $2.34 B |
7.61%
|
Dec 30, 2020 | $2.17 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
USA
|
Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
Altimmune
ALT
|
$0.49 B |
0.000 M
|
USA
|
Immunic
IMUX
|
$88.60 M |
-0.000 M
|
USA
|
Agenus
AGEN
|
$86.42 M |
0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
Market Cap | = | NYKD.OL Stock Price | * | NYKD.OL Shares Outstanding |
= | $0.24 | * | 0.33 B | |
= | $78.42 M |